Cargando…
LGG-15. Late mortality and morbidity of adult survivors of childhood glioma treated across three decades: a report from the Childhood Cancer Survivor Study
PURPOSE: Pediatric low-grade glioma therapy has evolved to delay or eliminate radiation. The impact of therapy changes on long-term outcomes remains unknown. METHODS: Cumulative incidence of late mortality (death >5 years from diagnosis), subsequent neoplasms (SNs), and chronic health conditions...
Autores principales: | de Blank, Peter M K, Lange, Katharine R, Xing, Mengqi, Salehabadi, Sedigheh Mirzaei, Srivatava, Deokumar, Brinkman, Tara M, Ness, Kirsten K, Oeffinger, Kevin C, Neglia, Joseph, Krull, Kevin R, Yasui, Yutaka, Nathan, Paul, Howell, Rebecca, Turcotte, Lucie, Leisenring, Wendy, Armstrong, Gregory T, Bowers, Daniel C, Okcu, M Fatih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164667/ http://dx.doi.org/10.1093/neuonc/noac079.330 |
Ejemplares similares
-
LGG-24. Neurocognitive impairment and functional independence in adult survivors of childhood glioma: A report from the Childhood Cancer Survivor Study (CCSS)
por: Papini, Chiara, et al.
Publicado: (2022) -
LGG-46. Survival Of The Fittest? A Prognostic Evaluation of Paediatric Low-Grade Glioma (PLGG) Survivor Functional Outcomes
por: Green, Katherine, et al.
Publicado: (2022) -
LGG-04. Clinical and molecular characterization of metastatic pediatric low grade gliomas
por: Lindsay, Holly, et al.
Publicado: (2022) -
LGG-10. AN UNUSUAL PRESENTATION OF BILATERAL OPTIC NERVE GLIOMA IN CROUZON SYNDROME
por: Na, Brian, et al.
Publicado: (2021) -
LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
por: Misek, Sean, et al.
Publicado: (2022)